4D pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. 4D pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34% to $718,000. Profit margin reached -4448%. Total operating expenses were $37,520,000.
Profit Margin
| 2014 | 0 | -2.38M | |
|---|---|---|---|
| 2015 | 0 | -7.73M | |
| 2016 | 0 | -9.86M | |
| 2017 | 0 | -20.44M | |
| 2018 | 0 | -23.69M | |
| 2019 | 211K | -24.06M | -11405.69% |
| 2020 | 534K | -25.96M | -4861.99% |
| 2021 | 718K | -31.93M | -4448.19% |
LBPS Income Statement (2014 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 718K | 534K | 211K | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 718K | 534K | 211K | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||
Research and development | 21.63M | 22.04M | 26.51M | 24.90M | 16.91M | 10.22M | 6.89M | 1.82M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 37.52M | 31.07M | 30.82M | 29.11M | 20.36M | 13.08M | 10.59M | 3.47M |
Operating income | -31.37M | -30.17M | -41.47M | -36.00M | -23.86M | -15.15M | -9.87M | -2.01M |
Other income (expenses), net | -581K | -173K | 12.04M | 7.56M | -123K | 3.45M | -184K | -364K |
Income before tax | -31.96M | -30.34M | -29.42M | -28.43M | -23.98M | -11.70M | -10.05M | -2.38M |
Income tax expense | -22K | -4.38M | -5.36M | -4.74M | -3.54M | -1.84M | -2.32M | 5K |
Net income | -31.93M | -25.96M | -24.06M | -23.69M | -20.44M | -9.86M | -7.73M | -2.38M |
Earnings per share | ||||||||
Basic EPS | -1.51 | -0.23 | -2.94 | -2.89 | -0.31 | -1.22 | -0.13 | -0.05 |
Diluted EPS | -1.51 | -0.23 | -2.94 | -2.89 | -0.31 | -1.22 | -0.13 | -0.05 |
| Data source | Data source | Data source | Data source | Data source |